• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    Chiesi Global and Protalix Announce EU Approval Elfabrio

    GLOBENEWSWIRE

    Chiesi, Protalix Seek EMA Re-Exam for Elfabrio 4-Week Dosing

    GLOBENEWSWIRE

    Chiesi, Protalix Get CHMP Negative View on Elfabrio Dose

    GLOBENEWSWIRE

    Chiesi, Protalix Announce EMA Validation for Pegunigalsidase Alfa

    PR NEWSWIRE

    Protalix &Chiesi Global Rare Diseases Announce USFDA (BLA) for Pegunigalsidase

    PRNEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.